Idenix Pharmaceuticals to Present at Needham & Company's Focus on Infectious Disease Investor Day
November 14 2008 - 4:05PM
PR Newswire (US)
CAMBRIDGE, Mass., Nov. 14 /PRNewswire-FirstCall/ -- Idenix
Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that Idenix
management will present a corporate overview at Needham &
Company's Focus on Infectious Disease Investor Day on Thursday,
November 20, 2008 at 9:00 a.m. ET at the Needham & Company
Headquarters in New York, NY. The live and archived webcast of the
company presentation can be accessed under "Calendar of Events" in
the Idenix Investor Center at http://www.idenix.com/. Please log in
approximately 5-10 minutes before each event to ensure a timely
connection. The archived replays will be available on the Idenix
website for two weeks following the conference. About Idenix Idenix
Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts,
is a biopharmaceutical company engaged in the discovery and
development of drugs for the treatment of human viral and other
infectious diseases. Idenix's current focus is on the treatment of
infections caused by the hepatitis C virus and HIV. For further
information about Idenix, please refer to http://www.idenix.com/.
Idenix Pharmaceuticals' Contacts: Media: Teri Dahlman (617)
995-9905 Investors: Amy Sullivan (617) 995-9838 DATASOURCE: Idenix
Pharmaceuticals, Inc. CONTACT: Media, Teri Dahlman,
+1-617-995-9905, or Investors, Amy Sullivan +1-617-995-9838, both
of Idenix Pharmaceuticals, Inc. Web Site: http://www.idenix.com/
Copyright
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jul 2023 to Jul 2024